Back
Nxera Pharma 10K Form
Sell
19
SOLTF
Nxera Pharma
Last Price:
$6.16
Seasonality Move:
12.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SOLTF News And Ratings
See the #1 stock for the next 7 days that we like better than SOLTF
SOLTF Financial Statistics
Sales & Book Value
| Annual Sales: | $91M |
|---|---|
| Cash Flow: | $10.3M |
| Price / Cash Flow: | 54.27 |
| Annual Sales: | $5.28 |
| Price / Book: | 1.17 |
Profitability
| EPS (TTM): | -0.27280 |
|---|---|
| Net Income (TTM): | $-24.6M |
| Gross Margin: | $68.9M |
| Return on Equity: | -5.58% |
| Return on Assets: | -2.38% |
Nxera Pharma Earnings Forecast
Key Nxera Pharma Financial Ratios
-
The Gross Profit Margin over the past 19 years for SOLTF is 75.70%.
-
The Selling, General & Administrative Expenses for SOLTF have been equal to 78.06% of Gross Profit Margin.
-
The Research & Development expenses have been 78.92% of Revenue.
-
The Interest Expense is -34.69% of Operating Income.
-
The Net Earning history of SOLTF is -56.34% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 7 years.
Nxera Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SOLTF |
| Website: | sosei.com |
Debt
| Debt-to-Equity Ratio: | 0.96 |
|---|---|
| Current Ratio: | 4.01 |
| Quick Ratio: | 3.73 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SOLTF Technical Analysis vs Fundamental Analysis
Sell
19
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy or a Sell?
-
Nxera Pharma stock is rated a SellThe current Nxera Pharma [SOLTF] share price is $6.16. The Score for SOLTF is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.